Agilent Technologies Inc vs Williams-Sonoma, Inc. — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Williams-Sonoma, Inc. trades at $250.52 (market cap $29.53B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Williams-Sonoma, Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| A | WSM | |
|---|---|---|
Market Cap | $42.00B | $29.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $251.81 |
52-Week Low | $110.24 | $168.64 |
Enterprise Value | $43.55B | $30.38B |
Dividend Yield | 0.69% | 1.21% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Williams-Sonoma (WSM) trades at $251.81, up 1.94% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, the company maintains robust profitability with a 13.81% net income margin and has beaten earnings estimates for three consecutive quarters. A dividend of $0.76 is scheduled for payment in August 2026, reflecting shareholder returns.
WSM's outlook is supported by consistent earnings outperformance and high profitability metrics like 54.01% ROE. However, valuation multiples such as a P/E of 28.23 appear elevated relative to historical norms. Key risks include consumer discretionary spending volatility and competitive pressures in home furnishings. Analyst consensus is mixed with a $222.22 price target below the current price, suggesting cautious optimism amid rich valuations.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →